Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-10.47%
-1.05%
+15.45%
+11.75%
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
02 Mar 2026$SABR Sabre Corp. surged 36.44% to $1.61 after announcing a one-year shareholder rights plan following Constellation accumulation of a 9.7% stake. The move reassured investors by providing a defensive mechanism against unsolicited takeovers and signaling board confidence in long-term value creation. Heavy trading volume of 35.35M shares, more than triple the 30-day average, underscores the market strong reaction. The combination of activist interest and structural protection has fueled a near-term rally, positioning Sabre as a key mover in travel technology equities.
$AERT Aeries Technology jumped 36.12% to $0.43 after announcing a $5 million share repurchase authorization. The board highlighted this move as a signal of confidence in the AI-driven business transformation services and growth trajectory. The authorization not only reduces share count but also demonstrates disciplined capital allocation, attracting traders looking for liquidity-driven gains in small-cap tech. Average daily volume is minimal relative to 15.13M shares traded, suggesting strong speculative momentum.
$ASTH Astrana Health climbed 29.46% to $26.32 following a better-than-expected Q4 report, where earnings came in at $0.54 per share versus a consensus of $0.11, and revenue reached $950.5 million against an expected $930.5 million. Management also provided ambitious guidance for 2026, targeting $3.8–$4.1 billion in revenue while continuing full-risk expansion. Investors rewarded the company for strong operating leverage and rapid growth in the health-tech sector. The surge amid a broadly down market highlights investor appetite for high-margin, growth-oriented healthcare plays.
$CGEN Compugen rallied 24.31% to $2.25 after posting a Q4 earnings beat, with GAAP EPS of $0.60 surpassing estimates by $0.55 and revenue of $67.33M beating by $53.03M. Positive developments, including non-dilutive funding for Rilvegostomig and advancement of GS-0321, reinforced confidence in the oncology pipeline. The combination of strong earnings and forward-looking catalysts positioned CGEN as a biotech leader attracting speculative capital, with volume nearly six times the average.
$LASR nLIGHT surged 20.47% to $67.69 on heightened interest in its high-energy laser and directed-energy weapon systems. The momentum was supported by the announcement to showcase a new 70-kW laser system along with recently introduced 30-kW and 10-kW systems at an upcoming operational science conference. Escalating Middle East conflicts and expanded defense budgets contributed to investor enthusiasm. The surge reflects both technological positioning in advanced weaponry and market sensitivity to geopolitical risk.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 5,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
